Laboratoire Biosanté U1292, Université Grenoble Alpes, INSERM, CEA, IRIG-Biosanté UMR_S 1292, 38000 Grenoble, France.
School of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Cardiovasc Res. 2022 Jun 22;118(7):1805-1820. doi: 10.1093/cvr/cvab187.
BMP9 and BMP10 mutations were recently identified in patients with pulmonary arterial hypertension, but their specific roles in the pathogenesis of the disease are still unclear. We aimed to study the roles of BMP9 and BMP10 in cardiovascular homeostasis and pulmonary hypertension using transgenic mouse models deficient in Bmp9 and/or Bmp10.
Single- and double-knockout mice for Bmp9 (constitutive) and/or Bmp10 (tamoxifen inducible) were generated. Single-knock-out (KO) mice developed no obvious age-dependent phenotype when compared with their wild-type littermates. However, combined deficiency in Bmp9 and Bmp10 led to vascular defects resulting in a decrease in peripheral vascular resistance and blood pressure and the progressive development of high-output heart failure and pulmonary hemosiderosis. RNAseq analysis of the lungs of the double-KO mice revealed differential expression of genes involved in inflammation and vascular homeostasis. We next challenged these mice to chronic hypoxia. After 3 weeks of hypoxic exposure, Bmp10-cKO mice showed an enlarged heart. However, although genetic deletion of Bmp9 in the single- and double-KO mice attenuated the muscularization of pulmonary arterioles induced by chronic hypoxia, we observed no differences in Bmp10-cKO mice. Consistent with these results, endothelin-1 levels were significantly reduced in Bmp9 deficient mice but not Bmp10-cKO mice. Furthermore, the effects of BMP9 on vasoconstriction were inhibited by bosentan, an endothelin receptor antagonist, in a chick chorioallantoic membrane assay.
Our data show redundant roles for BMP9 and BMP10 in cardiovascular homeostasis under normoxic conditions (only combined deletion of both Bmp9 and Bmp10 was associated with severe defects) but highlight specific roles under chronic hypoxic conditions. We obtained evidence that BMP9 contributes to chronic hypoxia-induced pulmonary vascular remodelling, whereas BMP10 plays a role in hypoxia-induced cardiac remodelling in mice.
最近在肺动脉高压患者中发现了 BMP9 和 BMP10 的突变,但它们在疾病发病机制中的具体作用仍不清楚。我们旨在使用缺乏 Bmp9 和/或 Bmp10 的转基因小鼠模型研究 BMP9 和 BMP10 在心血管稳态和肺动脉高压中的作用。
生成了 Bmp9(组成型)和/或 Bmp10(他莫昔芬诱导型)的单敲除和双敲除小鼠。与野生型同窝仔相比,单敲除(KO)小鼠没有明显的年龄依赖性表型。然而,Bmp9 和 Bmp10 的联合缺失导致血管缺陷,导致外周血管阻力和血压降低,并逐渐发展为高输出心力衰竭和肺含铁血黄素沉着症。双 KO 小鼠肺的 RNAseq 分析显示,参与炎症和血管稳态的基因表达差异。我们随后对这些小鼠进行了慢性缺氧挑战。在缺氧暴露 3 周后,Bmp10-cKO 小鼠的心脏增大。然而,尽管在单和双 KO 小鼠中遗传缺失 Bmp9 减弱了慢性缺氧诱导的肺小动脉肌化,但在 Bmp10-cKO 小鼠中没有观察到差异。与这些结果一致,内皮素-1 水平在 Bmp9 缺陷小鼠中显著降低,但在 Bmp10-cKO 小鼠中没有降低。此外,在鸡绒毛尿囊膜试验中,内皮素受体拮抗剂博森坦抑制了 BMP9 对血管收缩的作用。
我们的数据表明,BMP9 和 BMP10 在正常氧条件下具有冗余作用(只有同时缺失 Bmp9 和 Bmp10 才与严重缺陷相关),但在慢性低氧条件下突出了特定作用。我们获得的证据表明,BMP9 有助于慢性低氧诱导的肺血管重塑,而 BMP10 在小鼠的低氧诱导的心脏重塑中发挥作用。